SBC Medical Group reports Q3 EPS 12c, consensus 11c

Reports Q3 revenue $43.35M, consensus $45.78M. Yoshiyuki Aikawa, chairman and CEO of SBC Medical, said, “In Q3 2025, SBC Medical’s revenue decreased by 18% year over year. This decline primarily reflects the impact of our past business restructuring initiatives, including the revision of franchise fees and the deconsolidation of certain group entities. Meanwhile, rental revenue remained solid, supported by the renewal of medical equipment, and the consolidation of AHH contributed positively to overall performance.”